British American Tobacco p.l.c. (BATS) Earnings Call Transcript & Summary
February 12, 2026
Earnings Call Speaker Segments
Tadeu Marroco
executiveGood morning, everyone. It's a pleasure to have you join us for the presentation of our full year 2025 results. Joining me this morning are Javed Iqbal, our interim CFO, and Victoria Buxton, group head of investor relations. I'll start off with the highlights of our transformation. After that, Javed will walk you through our financial results in greater detail. Then I'll come back to discuss our performance outlook more and explain why the clear momentum we're driving gives us confidence in the pathway ahead. We'll then open things up for your questions. With that said, I'd like to point you to the disclaimers on slides 2 and 3. Let's start by examining the positive transformation momentum we're driving. First, some key highlights. We added 4.7 million smokeless consumers, taking our total to 34.1 million, mainly driven by our continued strong performance in modern oral. This represents our strongest growth acceleration to date and sets us up well for 2026. We delivered 2025 group results at the top end of guidance, driven by resilient delivery in combustibles and an excellent performance from Velo in all three regions. Our disciplined focus on quality growth continues to improve returns on more targeted investments, with new category contributing now up 77% at constant rates.
Tadeu Marroco
executiveOn top of that, we’re still committed to putting investment behind our premium innovation launches, which supports long-term value creation. We keep delivering strong cash returns to shareholders. Beyond our progressive dividend, in December we announced that our share buyback would rise to £1.3 billion in 2026. Looking forward, we’re confident about getting back to our mid-term algorithm this year, and the faster momentum during the second half of 2025 leaves us well placed to keep delivering. I’m proud that we’ve delivered on every one of our 2025 priorities, and I want to thank our teams across the world for driving these encouraging results. What we’re achieving reflects the clear momentum we’re building as we keep establishing a track record of delivery. I’d like to spend a moment on two areas from last year that stand out for me. First, revenue and profit growth both returned in the US for the first time since 2022 — a significant milestone driven by stronger combustibles performance, a return to revenue growth in vapor during the second half, and modern oral. As a result, we grew combustibles value share by 30 basis points. Second, we’re delivering quality growth in new categories, launching premium innovations in each category while returning to double-digit revenue growth in the second half and with category contribution growth up 77% for the full year.
Tadeu Marroco
executiveWhat we achieved in 2025 strengthens how confident I feel about what we will deliver going forward. That said, I'll now pass things to Javed, who will walk you through how we performed in 2025 in greater detail.
Javed Iqbal
executiveThank you, Tadeu, and good morning to all of you. I'm happy to report that our results came in at the upper end of guidance when measured on a constant currency basis. The driving forces behind this were a return to growth in the US, a robust showing in AME, and the global strength of modern oral. Our reported figures include some adjusting items, among them close to £1.6 billion that mainly relates to annual amortization of the US-acquired trademarks; a net credit of £524 million after a change in the forecasted outlook for the Canadian combustible industry; and we also booked a gain of almost £900 million from partially monetizing our ITC stake. So that you get a clear picture of underlying performance, my focus will be on constant currency, adjusted, and where applicable, adjusted for Canada matters. More detail on adjusting items and share data is available in the appendix. We delivered group results at the top end of guidance, helped by momentum that accelerated through the second half. Group revenue rose 2.1%, adjusted profit was up 3.4%, adjusted profit from operations climbed 2.3%, and adjusted diluted EPS increased 3.4%. Turning now to new categories revenue, it grew 7%, powered by outstanding growth in modern oral, which rose strongly by 48%, while heated products were up 1%.
Javed Iqbal
executiveThat was partly counterbalanced by an approximately 9% drop in vapor, driven largely by ongoing illicit-market pressures across the US and Canada. In the second half, Vuse results improved markedly compared with the mid-teens decline seen in H1, helped by early indications of vigorous enforcement action in the US. We keep delivering quality growth, with gross profit rising by more than £200 million and category contribution hitting £442 million. That mirrors our disciplined stance on return on investment, focused investment in high-value markets, and growing scale benefits throughout our portfolio. The progress we are making makes me proud, and I am especially happy with our faster H2 momentum, in which we went back to double-digit new category revenue growth. Moving now to combustible, revenue was up 1%, as volume decline was more than offset by sustained robust price mix across markets. Here, too, we achieved quality growth. Gross profit and category contribution each rose 2.5%, thanks to a strong US performance, positive price mix, and continued productivity and simplification gains, which I will address shortly. Our results demonstrate the breadth of our global footprint, as strong delivery in the US and AME more than offset fiscal and regulatory headwinds in Bangladesh and Australia, which affected total group revenue by roughly 1% and group adjusted profit from operations by roughly 2%.
Javed Iqbal
executiveThat resilience, together with rising momentum in H2, strengthens how confident we are about delivering going forward. Now to our regions, beginning with the US. Within combustibles, revenue rose 4.6%, as our stronger portfolio, tighter execution, and improved revenue growth management fueled price mix, including excise duty drawback. Value share was up 30 basis points, while volume share fell 10 basis points. In new category, revenue climbed almost 20%, powered by Velo Plus, which posted growth above 300%. Although vapor revenue declined 3.4% across the full year, we take encouragement from Vuse getting back to revenue growth in H2, helped by early signals from enforcement actions. All told, US revenue rose 5.5% and adjusted profit was up 5.9%, largely on the back of a strong combustible performance. Notably, Velo Plus turned positive on category contribution in its first year, which highlights how scalable our modern oral business model is. Tadeu will go into more detail on the US in a moment. In AME, we posted another robust performance. Revenue was up more than 3%, with combustible ahead by over 2%, helped by strong delivery in Brazil, Turkey, and Mexico alongside solid pricing. New category revenue rose 4.3%, chiefly on modern oral, which was up over 17%. We are the clear modern oral leaders in that region, holding over 60% volume share in top markets, selling at a premium, and outperforming peers by a wide margin, which Tadeu will cover later.
Javed Iqbal
executiveHeated products gave growth an extra lift, with revenue rising more than 6%, led by Italy, Germany, and Ukraine. Partly offsetting that were competitive pressures in Romania, where we shifted resources ahead of the glo Hilo launch. Vapor revenue fell by over 11%, largely because of weak illicit-trade enforcement in Canada plus regulatory and excise changes in the UK, France, and Poland. Adjusted operating profit was up almost 10%, helped by operating leverage and efficiency gains in combustibles, along with scale benefits and resource allocation that lifted contribution across all three new categories. AME is genuinely a multicategory region, producing high-quality growth and showing how resilient and balanced our portfolio is. In APMEA, gains in key markets such as Pakistan, Nigeria, and Indonesia were more than outweighed by fiscal and regulatory headwinds in Bangladesh and Australia. Total revenue dropped 7.2%, as combustibles fell 8.3%. New category revenue was 7.6% lower. Robust modern oral growth was more than offset by intensified competitive activity in heated products within the value-for-money segment in South Korea and Japan, together with the phase-out of our super-slim platform. Our vapor results reflect strategic choices made to shrink our footprint and move resources away from markets whose regulation and enforcement do not support a responsible competitive landscape.
Javed Iqbal
executiveAdjusted profit declined 17.9%, largely because of difficulties in Bangladesh and Australia. As we keep working through headwinds into 2026, we anticipate that our performance will steady across the full year, helped by Bangladesh as we anniversary last year's drop and as the Australian drag becomes increasingly immaterial compared with the prior year. Now shifting to group operating margin, which stayed roughly level at 44%. We managed to counter inflation and FX pressures thanks to a robust US result, greater profitability in new categories, and ongoing cost reductions. Transactional FX headwinds affecting adjusted profit came to roughly 1%, driven chiefly by Turkey, Japan, and Nigeria. At the current rate, operating margin grew by nearly 10 basis points. BAT has a solid history of discipline and cost savings, and we keep strengthening that base. Since 2023, productivity savings of £1.2 billion have been achieved. Such efficiencies assist us in countering inflation and foreign exchange headwinds while we go on funding innovations and growth in new categories. During 2025 by itself, we took on about £300 million of inflationary cost rises on top of transactional FX. Going forward, our focus stays on simplifying combustibles and expanding new categories, with a goal of a further £2 billion in productivity savings by 2030.
Javed Iqbal
executiveBeyond that, we now anticipate that our Fit to Win initiative will generate £600 million in annualized incremental savings by 2028. Of that total, roughly £500 million should be achieved by 2027, and the remaining benefits will come through by the close of 2028. These savings will be reinvested, we are committed to that, in order to back additional sustainable growth efforts. Fit to Win is a transformational undertaking that is reinventing BAT. As we set out at our 2025 half-year results, its focus is on optimizing processes and ways of working so as to build a leaner, faster, and more data-driven organization. Strong progress has been made since half year. We have broadened the program to encompass organizational streamlining that sharpens focus and improves speed of execution, which lets us lift total annualized savings by a further £100 million. To unlock these benefits, we now expect associated costs of around £600 million across the next 2 years. As a structured, time-bound program, £500 million will be treated as adjusting, including approximately £100 million of noncash items. This spend, as previously guided, is already underway, with most of the costs expected to be incurred this year and concluding in 2027. Taking it all together, earnings per share rose by 3.4% as operating profit growth and a lower share count were partly offset by net finance costs, our reduced share of ITC profits, and tax.
Javed Iqbal
executiveOur underlying tax rate came in at 24.5%. We keep generating strong cash, which adds to our financial flexibility. That has let us announce a 2% rise in our dividend and lift our share buyback by £200 million, taking it to £1.3 billion for 2026. On top of that, at the close of 2025 we delivered 2.55 times adjusted net debt to adjusted EBITDA, and we're still on course to land inside our 2 to 2.5 times target range by year-end. Our 2025 cash delivery took a hit from the CCBA upfront payment and from the prior-year deferral of tax payments in the US, yet we're still on track to generate more than £50 billion in free cash flow by the end of 2030. Our capital allocation priorities remain our focus: investing in transformation, balancing deleveraging with progressive dividends and sustainable share buybacks, and selective bolt-on M&A to support our transformation. I'm excited about what's ahead and confident we can deliver our mid-term algorithm of 3% to 5% revenue growth, 4% to 6% adjusted profit from operations growth, and 5% to 8% adjusted diluted EPS growth. Getting back to this mid-term algorithm in 2026 is a major milestone in our transformation journey, and it reinforces how strong and resilient our strategy is.
Javed Iqbal
executiveWhat gives us that confidence is ongoing expansion in the US; strong multicategory performance in AME; new category revenue increasing by a low double-digit rate, led by Velo around the world; additional gains in new category contribution; and ongoing savings from our productivity programs. While more work remains ahead of us, and stabilizing performance in APMEA will take time, we'll keep investing in rolling out our premium innovations. Consequently, we anticipate 2026 landing at the lower end of these ranges, with our profit performance weighted toward the second half, driven by the phasing of new category investment and as Fit to Win savings accumulate over the year. With that, I'll turn it back over to Tadeu.
Tadeu Marroco
executiveThank you, Javed. Now let's turn to the positive transformation momentum that we're driving. Back in 2023, when I took on the Chief Executive role, I made a commitment to sharpen our focus and our execution, guided by a refined strategy and by the ambition of becoming a predominantly smokeless business by 2035. I'm proud to report that we've achieved meaningful progress across all 3 strategic pillars as we keep building a track record of delivery. There's still more to do, but I'm confident that our focus, our investments, and sharper execution are generating real momentum, as our 2025 results make clear. This progress underpins our confidence in sustainably delivering our mid-term algorithm while we continue rewarding shareholders with strong cash returns. Let me now highlight 5 points that demonstrate this. First, we've successfully reset our US business, returning to revenue and profit growth in 2025. Although the US macroeconomic environment remains dynamic, the pace of combustibles industry volume decline began to moderate in 2025, down 7.4%. Against that backdrop, driven by the actions we've taken to strengthen our portfolio and sharpen execution, our US combustibles business delivered strong revenue and profit growth in 2025. Driving value from our combustible business is essential to funding our transformation, and the US is a key driver of this.
Tadeu Marroco
executiveConsistent with that approach, we picked up 30 basis points of share across the total industry value. It's especially encouraging to me that our financial results picked up pace during the second half. That favorable momentum strengthens my belief in how resilient our US combustible business is and in our capacity to generate sustainable value down the road. In the world's biggest modern oral value pool, Velo Plus stands as the modern oral brand growing fastest. Launched at the close of 2024, it has already climbed to the number two spot in volume and in value share, adding almost 18 percentage points of volume share and close to 14 points of value share. We're glad to see that share momentum carry on into the beginning of 2026. Velo Plus has grown its consumer base by more than 2x and produced modern oral revenue growth above 300%, while capturing roughly 70% of industry volume growth and 80% of industry value growth in December. A steady repurchase rate of about 70% during the year underpins all of this. Importantly, we delivered positive category contribution inside the first 12 months after launch, in full alignment with Velo's global payback profile. The overall US modern oral category keeps expanding robustly and has now surpassed the size of the legitimate vapor category, with more than £2 billion of revenue in 2025.
Tadeu Marroco
executiveVelo Plus is a strong offering, and these figures show as much in a category that is still very dynamic. That impressive performance also underscores the wider strength of what we can do in the US and how well we execute — spanning consumer insights and branding through to upgraded digital analytics and distribution, all made possible by a revitalized Reynolds. Our results got an extra lift from the summertime launch of Grizzly Modern Oral, which had captured nearly 2% volume share by the close of the year and lifted our overall share of US modern oral volume to 25.8%. With that kind of momentum, I'm pleased to report that as the year ended, we attained the number one position worldwide by volume share in modern oral, as measured across the leading modern oral markets, which account for roughly 90% of total industry revenue. Second, we're moving our new category portfolio upscale. Velo already stands as the unmistakable leader in Europe, roughly six times the size of our closest rival. We remain focused on consumer-driven innovation to boost product satisfaction for adult consumers and build on Velo's success. Early this year, we started rolling out nationwide in Sweden our newest innovation, Velo Shift, after a successful pilot with major retailers and online partners. Velo Shift is transforming the modern oral experience, with a new comfort pouch design, five distinct sensory flavors, and a differentiated can that stands out on shelf.
Tadeu Marroco
executiveVelo Shift, priced above the core Velo lineup, is already generating added share in the channels where it's been introduced, and we intend to roll it out to more markets during 2026. What these numbers show is not just how strong the Velo brand and its innovation pipeline are, but also how well we execute across European markets. Premium vapor, when done properly, strikes us as a very appealing segment that remains untapped for creating further value. Vuse Ultra is the most advanced vapor device we've brought to market so far, and it's delivering a substantial performance lift for Vuse in the markets where it has launched — value share gains of nearly 8 percentage points in Canada, close to 4 percentage points in Germany, and above 2 percentage points in France. As Javed pointed out, we've taken proactive strategic steps to concentrate our execution on the biggest profit pools, where regulation and enforcement are more supportive. Vuse Ultra sits at the heart of that strategy, and its early performance gives me encouragement, with additional launches set for key markets in 2026. Our breakthrough innovation platform, glo Hilo, brought out our first two-piece device and is built to plant glo firmly in the premium segment. It's still early, yet we're beginning to see encouraging results in the priority launch markets — Japan, Poland, and Italy — and most consumers who are new to glo are arriving from both premium combustibles and the wider heated products category.
Tadeu Marroco
executiveWe're also reinforcing glo's overall brand equity on the key consumer metrics. That consumer reaction is showing up as early momentum in volume share. We're encouraged by early trial-to-retention rates of about 50%, which gives us added confidence in the platform's potential. During 2026, we'll focus on accelerating trial among premium consumers in both combustibles and heated products, backed by targeted online and in-person activations. We'll keep scaling glo Hilo through further market rollouts in the biggest heated product profit pools, where returns can be strongest. All in all, we remain confident in the strength of this innovation platform and expect to build share within the premium segment progressively over time. As Javed highlighted, the heated products category stayed highly competitive, and that has affected our 2025 performance in the value-for-money segment, where we compete with glo Hyper. Bringing glo Hilo into the premium space lets us further differentiate and tier our portfolio. We see a clear opportunity to strengthen glo's overall performance across both premium and value-for-money segments. Central to this is the launch of our next-generation glo Hyper device from Q2. The new glo Hyper delivers a step-change offering: quick start, longer standard session length, new connectivity, and a replaceable battery.
Tadeu Marroco
executiveAll of these changes make a real difference for consumers, and on top of that we're continuing to broaden what the consumables lineup offers. Put together, the result is a far more compelling proposition, built to strengthen how we compete in the value-for-money tier. Next, I take real pride in how much headway we've made on making the new categories more profitable. From 2021 onward, we've delivered a £1.4 billion gain in category contribution, and each of the three new categories has played a part in that momentum. What matters is that we did this even as we kept funding our transformation, so that future growth stays sustainable. Our new categories now make a meaningful mark on group results, since greater scale is paying off — evidence of traction in established markets even while we keep putting money into launching in new ones. More consistent and constructive regulation underpins this, for example the frameworks now in place for modern oral across 24 markets, versus a mere 4 markets back in 2022. Year after year we've improved in sequence, and with our quality growth approach we stay committed to delivering steady profitability gains going forward. Then fourth, I'm heartened by early signals of positive movement when it comes to regulating and enforcing the new categories, particularly in the US. The vapor category is still being hit by the spread of illicit products, yet Vuse got back to revenue growth during the second half, following 18 months of decline.
Tadeu Marroco
executiveStronger enforcement at the state level has backed this up, with legislation on vapor directories and enforcement accounting for roughly 50% of tracked industry volume by year-end. On top of that, Vuse's second-half results got a lift from a competitor leaving the market, which made our market position even stronger. Early indications of tougher federal enforcement aimed at borders and bigger distributors have also aided our recovery, producing large seizure and fine totals. Going forward, we're encouraged by the greater attention and money being put toward bolstering the FDA's enforcement capacity. We were also glad to get a favorable initial determination from the administrative law judge on our International Trade Commission complaint; the judge has recommended a general exclusion order covering imported illicit vapor devices. A final determination from the ITC should come in the next few weeks, after which a 60-day presidential review applies. With an estimated 70% of US vapor industry value still illicit, we hope the authorities will keep pursuing enforcement initiatives in 2026. Reynolds will keep pushing for a level playing field so adult nicotine consumers can get high-quality, compliant vapor products. In time, we think Vuse is well placed to gain from robust enforcement at both the federal and state levels.
Tadeu Marroco
executiveAlso, the FDA has lately acknowledged the beneficial part nicotine pouches are able to play in assisting adult smokers—people who would otherwise keep smoking—to move toward lower-risk alternatives, which reinforces their place in tobacco harm reduction. We welcome the FDA's new pilot program aimed at streamlining the PMTA review process for nicotine pouches. That marks a significant step toward keeping illicit products that appeal to underage users out of the market, while giving responsible manufacturers a more predictable route to PMTA authorization. We have confidence in the strength of our science and portfolio, and we look forward to complementing our current US portfolio with Velo Max, a higher-moisture modern oral product, in 2026, and we have raised capacity to support our sustainable growth agenda. The last point I want to highlight is that our financial flexibility keeps getting stronger, and we remain on track to produce more than £50 billion of free cash flow by 2030. BAT is a business that generates a great deal of cash, delivering at least 100% operating cash conversion annually since 2020 to 100% of operating cash conversion—reflecting our strong cash discipline and clear focus on returns, and enabling us to return £34 billion of cash to shareholders over that same period.
Tadeu Marroco
executiveOur dedication to generating sustainable returns for shareholders is unchanged, backed by a 25-year record of raising dividends and our sustainable share buyback program. I have confidence that we will deliver our mid-term algorithm sustainably, since we are solidly committed to growing revenue in a sustainable way and to improving profitability. In closing, we are bringing momentum into 2026, supported by a robust innovation pipeline, strong strategic partnerships, and confidence in our future fit capabilities. We are executing with discipline and delivering against our priorities. Meanwhile, we are strengthening financial flexibility, which enables continued investment in our transformation, along with strong cash returns. I am excited about what lies ahead for BAT and believe we are well positioned to deliver long-term sustainable growth and value for all our stakeholders. Thank you for listening. Victoria will now join us on stage for the question-and-answer session.
Victoria Buxton
executiveThanks, Tadeu, and good morning to all of you. Should you be with us on the webcast, you're able to enter your question right into the online question box, or, in the event that you joined the call, you can press *1 on your telephone keypad. Tadeu and Javed will be very glad to take your questions, and I'll now pass things over to the conference call operator.
Operator
operatorThanks. The first question comes from Andrei Andon-Ionita at Jefferies. Sir, go right ahead.
Andrei Andon-Ionita
analystMorning, Tadeu, Javed, and VB — I really appreciate you taking my questions. I have two on modern oral, please. First, for fiscal 2026, what performance are you expecting specifically in the US for modern oral? Second, do those expectations rest on the FDA clearing the European Velo product for sale in the US, or do they come mainly from the existing Velo Plus product? And lastly, on profitability, could you say a bit more about how you see new categories profitability developing in fiscal 2026? Thank you.
Tadeu Marroco
executiveAndrei: Thanks for asking. So, Velo Plus is a really strong product for us in the US. Retention levels have held at 70% all year, and that's a genuinely very strong rate when you stack it up against other offers out there in the market. On the back of that, we think the product is capable enough to keep growing in the US market, and all the signs point that way. Right now, brand awareness is still low, at about 30%. We're in more than 150,000 outlets at this point, and those represent roughly 93% of total oral revenue. We're also seeing average daily consumption rise as new products become more satisfying for consumers in the US. It used to be about 2.8 pouches per day, and now it's about 3.6 pouches per day. Compare that with the European market, at around 6 pouches per day, and you can see there's still plenty of potential growth in the US. The Nordics is 12 pouches per day. When you pull all of this together — a strong product and market dynamics evolving at the pace they are in the US — the expectation is that we'll keep growing.
Tadeu Marroco
executiveThat is the reason we're putting money into capacity, as I said in my presentation. We brought up Velo Max, an item with even greater moisture that forms part of the pilot the FDA is running. First of all, we're glad the FDA is treating nicotine pouches as a major category for tackling tobacco harm reduction in the US, since it carries the lowest risk profile, if you will. You don't inhale anything, there's no tobacco, there's no odor, and it's far simpler for cigarette consumers to switch to a product with a much lower risk profile. They're setting up these pilots. We're hoping that over the coming few months we'll see our products, and we're mindful that rival companies will bring out their own products too. That's no issue for us, because when I look beyond the US, where anybody is free to compete, the top brand outside the US is Velo. As we've said, in Europe our Velo volumes are six times larger than those of the second-biggest competitor. What we'd like to see in the US is a level playing field, since on a level playing field we know we can win.
Tadeu Marroco
executiveThat's the first question about Velo. On profitability, we've delivered a really substantial gain when you look back to not so long ago — in 2023, we were only just getting to breakeven in this category, and now we're at a 12% category contribution. Of course, I've always said this won't be linear from one year to the next, since some years will see us put money back into the business on the back of exciting innovations, and 2026 is one of those years, because as I mentioned in my presentation, we now have premium innovation across every one of those categories. We want to launch glo Hilo, we want to launch Velo Shift, we want to keep launching Vuse Ultra. We're not worried about setting a particular pace for category growth year-on-year, because that will change over time, but the trend is very clear: the category will keep growing.
Operator
operatorThanks. Our next question comes from Faham Baig at UBS. Go ahead, please.
Faham Baig
analystMorning, everyone, and thanks for taking my question. First, on the full-year 2026 guidance: you've pointed to the low end of the mid-term targets. It would be helpful if you could share the factors that might push performance—whether in 2026 or after that—into the middle or even the upper half of the range. Second, on heated tobacco: I take it 2025 was a difficult year on share. How are you thinking about share movement through 2026, especially with competition in the category heating up?
Tadeu Marroco
executiveThank you, Faham. Look, I'd like to take the second one first, and then we'll get to the guidance. We clearly see areas where our performance in heated products can improve. What we observed throughout 2026 is that the below-waist segment, which is basically where we were present until glo Hilo launched later in the year, has been very competitive in some of the key markets. That's why I made the point today that we are coming with a revamped Hyper product that we believe, together with revamped consumables, will strengthen our position in that particular segment. We are very encouraged by what we have seen of this product's performance, and in the initial tests that we have been doing. We believe this will support our performance moving forward. Obviously glo Hilo will complement that, because it's the first attempt we have done where 70% of the value of the category sits, which is the A-WAAP, the premium part of it, and we are extremely pleased with the performance. We are growing week after week with a level of retention of 50%, and this, complemented by a revamped value-for-money proposition, gives us the confidence that we can revert this trend and start growing from here.
Tadeu Marroco
executiveRegarding guidance now, I think Javed can go into a bit more detail on 2026. I just want to point out that after 2 years of investment to reset our business — the US business and our innovations pipeline — BAT is ready to return to the mid-term algorithm that the company has always had, roughly 3% revenue, 5% revenue, leading to 4% to 6% operating profit, with a kicker of about 1% to 2% for EPS, which is the 5% to 8% range. Naturally, our targets incorporate transaction FX — I always try to give this disclaimer about BAT's targets. The growth profile across these ranges will now differ from where we were, I would say, several years ago, because the new category will be even more prominent within that. Out of the 3% to 5%, we have said before that we expect combustible to deliver around 1% to 2%, with the US in the medium term between 0% to 1%, and the rest of the group, the international part, I would say the other two regions, above 2%. In 2025, despite all the difficulties we face mainly in the APMEA region, we were able to deliver 1%.
Tadeu Marroco
executiveWe mentioned that Bangladesh and Australia each hit the top line by 1%, and without them we'd have landed at the high end of that range. Looking ahead, I have a lot of confidence that we can deliver comfortably inside that range. To get the algorithm working in new categories, we needed double-digit growth there. That didn't happen in 2025, largely because of the headwind in vapor. Several factors played into it, but the main one was the illegal market in the US, where we're now seeing signs that the authorities — whether federal or state level — are tackling it. Going forward, we expect vapor to be less of a drag and eventually even a tailwind supporting the category for BAT. THP, which we just discussed, should see us accelerate growth from here on with all the offers. And modern oral — we now have a leading brand there, and we expect to go from strength to strength. I'm very confident we can deliver double-digit new category revenue growth and 1% to 2% on the combustible side. That flows through to the 4% to 6% margin improvement, backed by all the productivity savings we've already mapped out through 2030.
Tadeu Marroco
executiveTo be specific, for 2026, I'd like Javed to comment on that.
Javed Iqbal
executiveThanks, Tadeu. On 2026 in particular, I'll take it region by region and then we can step back to the total picture. For APMEA, as I mentioned, our expectation is that Bangladesh won't be a major drag, while Australia is still a meaningful drag — though that gets smaller each year. In 2026 Australia will remain a drag, but by 2027 it will matter less. That said, we'll keep putting investment behind rolling out premium innovations in APMEA too, as you've seen with glo Hyper, so we'll be positioned there as well. Another point in that area: for AME, we're still dealing with headwinds from the illicit vapor environment, plus the regulatory changes in Poland that came at the end of the year and pushed legal vapor out of the market — another drag for us. Turning to the US, bear in mind the comparator from 2024 to 2025 is very different from 2025 to 2026. We performed very well in 2025, so the comparators shift. And for now we're assuming stable volumes for Vuse in the US.
Javed Iqbal
executiveOur expectation is that enforcement at the level witnessed thus far will halt the decline, while overall volume stays steady. In addition, as we pointed out in the pre-close trading update, we are pulling out of some geographies that aren't adjusted, though those exits will affect our figures in 2026. Hopefully that provides some sense of the reasoning behind the lower end for 2026. That said, everyone here takes real pride in and feels strong confidence about this business as we begin year one of our mid-term algorithm.
Faham Baig
analystThat was very thorough. Thank you both — I appreciate it.
Operator
operatorThank you. We’ll take the next question from Rey Wium at Anchor Stockbrokers. You have the floor.
Rey Wium
analystGood day, Tadeu, Javed, Victoria. Hearing how upbeat you are about the new categories is quite interesting. I took a quick glance at the numbers. Clearly, modern oral is performing exceptionally well. Vapor gives you a chance to at least stabilize, and on heated tobacco, I'm not sure whether the jury is still out there, but I don't know if you can speak at a high level here, to give us a sense of which of these categories excites you most, or makes you most excited, regarding future growth in that respect, especially now as we head into 2026, when we speak of double-digit revenue growth. Then just a follow-up, just on Australia. It's quite interesting, because I sit in this market. The legal market has now fallen to 3 billion sticks or less. Now, clearly, if I look at Japan, that's basically what Japan will consume in the space of 7 days. It's hard for me to understand why you say it will still be a drag. Isn't it about time that you could consider exiting this market? I'm just curious to hear your thoughts on that. Thank you.
Tadeu Marroco
executiveAll right, all right. So on those new categories — clearly, modern oral is the exciting one among the three. The speed at which modern oral is expanding globally is very evident. Even in places lacking an oral tradition — take the UK as an example — when we introduced Velo there 4 years ago, oral nicotine incidence stood at 0, and now it's roughly 3%, and occasionally it can reach as high as 4% in terms of Vuse. This same thing is occurring in places like Poland, and it's occurring in emerging markets since it's very affordable — like Pakistan, which is performing extremely well, South Africa performing extremely well, Kenya. The potential here is massive, and we're very pleased that 24 markets have already passed legislation. The most recent one was actually Argentina a few weeks ago, and Portugal has just passed legislation too. We clearly see a lot of potential in this category, and obviously we're very pleased to have a leading brand in it. As for tobacco heating product, it's a £9 billion revenue category, and BAT has just below £1 billion in it. There's a lot of white space for us.
Tadeu Marroco
executiveCompetition has kept intensifying, yet we now have a product sitting in what you might call the value segment of the category, and on the premium side too, which was never the situation previously. With glo Hilo, we're tapping into a subcategory inside the category for BAT that has been very, very much untapped, and we're extremely excited about this chance to take up some of that white space in a category that continues to grow — not at the same rate as modern oral, obviously, but it still grows at a mid-single digit or high single digit. Vapor is a difficult category given the lack of enforcement and/or regulation, and that's why we have — it's actually hard to compete with some of these illegal products, or products that don't have concerns when it comes to a responsible way of doing vapor. That's why we came out with this campaign, because you see a proliferation of devices with thousands of puffs that carry a very different negative risk profile from the ones we sell. There is no level playing field. The reason we're addressing a premium subcategory within vapor with products like Vuse Ultra is precisely a recognition of that.
Tadeu Marroco
executiveWe aren't truly fighting over volume—we're fighting over value, and giving consumers a responsible method for vapor. Clearly, the US is the biggest vapor market, and all eyes are on the FDA, which I believe has now offered some signals that it recognizes the absence of a level playing field is also at the root of the problem. With luck, we'll see some of the pilots they're currently running on nicotine pouch extended into vapor down the road too. Those are the new categories. Australia—well, Australia has had, ever since plain packaging arrived in 2012, a badly misguided and illogical set of regulations year after year, plus excise rising far above inflation, to the point that today the typical price of a cigarette in the legal Australian market exceeds the equivalent of £20—£22—while illicit products sit at roughly £6. Because of this, 65% of the combustible market is now illegal. They have, in effect, lowered the average price consumers pay, and for the first time in many years we're seeing an uptick in smoker incidence in Australia. Not only have they gutted tax collection, but through this illogical regulation they are now incentivizing consumers to smoke a product far cheaper than the legal market—and naturally to keep up all the criminality, as we've witnessed across many different markets.
Tadeu Marroco
executiveSo the effect on us is this: that market has always mattered a great deal to BAT, and, as Javed said, there will come a point where it becomes insignificant. The drag in 2026 won't be the same as in 2025. It's still a drag, but it won't be the same. From then on, if the government keeps doing that — and it looks like it's heading toward 100% illegality anyway — we don't even need to make a decision to leave, because the direction of travel has been very clear. If you add the vapor category, which has an incidence of 9% of adult consumers and is 100% illegal today, then 85% of nicotine consumption in Australia today is illegal. It's just a question of a couple of years, and unless they decide to do something more reasonable, no?
Rey Wium
analystThanks a lot.
Operator
operatorAlright, the next question comes from Pallav Mittal at Barclays. Go right ahead.
Pallav Mittal
analystGood morning, and thanks for taking my question. I have two. First, on the US business, your price mix is clearly quite strong at 12%-plus. Could you help us understand what share of your US volume portfolio currently benefits from the excise duty drawback, and how much room it has to grow going forward given your global business? That's the first one. Second, I appreciate all the commentary on your NGP guidance for 2026, but your low double-digit growth still seems to assume a pretty sharp normalization compared with what we can see in the data, especially on nicotine pouches and the e-vapor side. Could you help us understand the moving parts behind your low double-digit guidance for 2026?
Tadeu Marroco
executiveAll right, Javed is going to handle your second question. Regarding duty drawback, that's legislation in the US that has existed for a long time, designed to encourage manufacturing locally and boost exports from the US. Clearly, that is precisely what we're doing. Over the past couple of years, Reynolds has put more than $200 million into manufacturing. We generated over 800 jobs, our purchases of leaf in the US rose by 65%, and Reynolds today ranks number one by volume of leaf purchased in the US market. We aren't disclosing specifics on the duty drawback impact, but here's one data point to consider: our revenue in combustible would have been positive even without the duty drawback. That's important to mention, because ultimately, going back to what I referenced regarding the long-term algorithm, we expect the US combustible market to decline at rates of roughly 6% to 7%, and given the elasticity that still exists in the market, this should give Reynolds the possibility of reaching positive revenue of around 0% to 1%.
Tadeu Marroco
executiveIn recent years, it's actually been higher than that, since the company is performing extremely well when it comes to how strong the portfolio is, and the duty drawback is also providing a boost in that sense. Aside from the duty drawback, we remain positive, and I feel quite comfortable with the range we've set for ourselves under our long-term algorithm.
Javed Iqbal
executiveRegarding the overall new category revenue guidance in the low double digits, there are a couple of points. First, in the US, as I explained during my presentation, we recorded a negative number for the full year on Vuse. Our expectation is that Vuse numbers will be flattish, since stronger and more meaningful enforcement will be required, and given a very complex and long supply chain, even those measures will take time before producing a meaningful impact. Even the ITC regulation that Tadeu mentioned, if it gets passed through, meaningful impact will only be seen much later in the year. That said, as I also highlighted, regulations such as the one in Poland in Europe have put a drag on Vuse volume, because they have made the legal business all a negative in those numbers, so entering that market is not possible. Also, the highly competitive environment we see in the bewap segment within the heated product portfolio, as we discussed earlier, that competitiveness will continue to be there for the short term. Putting all this together, that is why our guidance sits at the low end of the teens.
Javed Iqbal
executiveThat said, over the medium term we have a lot of confidence that Velo is going to drive new category revenue growth — it's the fastest-growing brand in the fastest-growing new nicotine category worldwide, the US included. That being said, with all of those points in mind, that's the reason we've guided on this front at a low teens level for the time being.
Pallav Mittal
analystThanks.
Operator
operatorSimon Hales of Citi has our next question. The floor is yours.
Simon Hales
analystThank you. Good morning, Tadeu. Good morning, Javed. Good morning, VB. I have a couple of questions. First, I'd like to return to a few of the remarks you just made about the US business looking ahead. Javed, going back to the vapor performance point and the expectation of flat vapor for 2026, I'm still trying to reconcile that, since you've had fairly strong exit rate momentum through the second half of the year. I understand that enforcement actions in vapor don't follow a straight upward line, but we'll probably still annualize, at least through the first half, some of the building enforcement we saw in 2025, and one would imagine that should help the vapor category — or the legal vapor category — in the first half. So are you expecting that as we get into H2 of 2026, your Vuse business will be down year-on-year, in order to get you back to that flat guidance for the year? That's the first point. Then secondly, on the US, today you mentioned 6% to 7% as the normal, helpful run rate of decline on combustibles volumes. Do you expect to see that in 2026? Could you also perhaps talk a little about what you're doing in discount at the moment, how Doral performed last year, and your plans for that brand going forward?
Javed Iqbal
executiveIf I start with the first point, I think what I need to emphasize more regarding Vuse's performance in the US during the second half of 2025 is that, apart from enforcement, there's another item that won't repeat — the delisting of a competitor's product, from which Vuse benefited: 63% of those consumers stayed within closed systems, and in an RCS system, Vuse captured more than its fair share of our category. That's another factor boosting Vuse's second-half performance. I wouldn't carry that second half forward into the full year of 2026. For the full year of 2026, it's more focused and will depend more on the level of enforcement we observe. As Tadeu also highlighted, although regulation now covers 40% of the legal volume, enforcement levels differ from state to state. First, we won't have that one-off from the competitor's exit, where we gained more than a fair share, and enforcement still appears to be in its early days — that's why I made that comment in our guidance on Vuse.
Tadeu Marroco
executiveOn the volume side, what I'd say is more of a hypothetical situation. It isn't a 2026 comment. Here's what's happening in the US market. If you look back at 2020, 54% of nicotine users were consuming traditional nicotine products — combustible and traditional oral. If you look at 2025 now, that figure is 34%. What's going on is that these consumers are transitioning either to poly-usage or to becoming solo users of smokeless products, whether modern oral or vapor. Obviously, the secular decline tied to ADC and the incidence level coming down over time, around 4%, is not going to return. That's my point. Even if you see meaningful enforcement in vapor, in disposables — and we know that currently plays a role in how much cigarettes are declining — even if we see that, even if we see an improvement in US macroeconomics, it's very hard to imagine the market returning to a 4% decline, given the dynamic of poly-users and solo users in the new categories I was referring to. My point is that, over the long run, with meaningful enforcement in disposables and with macroeconomics strengthening, between 6% to 7%, I think that where we stand today, in the next couple of years, in the scenario we're seeing, I think a performance in 2025 of around 7% to 8% is the more reasonable one to assume.
Tadeu Marroco
executiveThat's what I'd figure. Now, clearly, this is the overall market. Once you split out the overall market, the deeper discount segment has a very different dynamic. We're seeing more activity from competitors there, and as a result, deeper discount grew 10% in 2025. That was even higher than the 7% growth they posted in 2024. To your question, we've been piloting Doral. We've always been very mindful, because even though the deeper discount is growing, unlike the general market, 90% to 95% of the value still sits outside the deeper discount. We're very mindful when it comes to testing the product, which in this case is Doral. We ran pilots in Louisiana and in West Virginia. What those pilots are showing suggests we'll be able to expand Doral into other states as well, taking into account the source of business and possible downtrades of our own brands. We're doing that with value in mind. We're not doing it for the sake of market share. We want to expand Doral in the states that make sense from a value standpoint.
Simon Hales
analystUnderstood — thank you very much.
Operator
operatorFelton Agaud from Bank of America has the next question. The line is yours.
Bastian Agaud
analystGood morning. This is Bastian calling from Bank of America. Thanks for taking my question. I've just got one quick item regarding the buyback. Your net debt sits near the 2.5 target, and free cash flow for 2025 came in quite strong. So my question is this: on the buyback, £1.3 billion for 2026, what sort of margin do you have to potentially raise it at some point or another over the course of the year? As I understand it, roughly 70% of your debt is in dollar, which could be fairly volatile on that front. I just want to understand the moving parts on your buyback for the full year 2026. Thank you.
Javed Iqbal
executiveI think, Bastian, thanks so much. Back in 2024 we launched a sustainable share buyback program, beginning at £700 million. Today we're at £1.3 billion, with a £200 million increase for 2026. Our focus stays on cash, and on delivering as well. We need to get into that 2 to 2.5 times range, and we also want to make sure we keep delivering an additional incremental dividend in sterling terms, keep up our record of 25 years-plus on that front, and keep a sustainable share buyback going. What we want to ensure is that we create more optionality for capital allocation over the medium to long term for the business. For now, I'm very comfortable with the £200 million increase we've made, from £1.1 to £1.3 billion for 2026, and we'll keep focusing on generating cash to bring us back into our 2 to 2.5 times range and continue a sustainable buyback.
Bastian Agaud
analystThanks a lot.
Operator
operatorThanks. We’ll take the next question from Damian McNeela at Deutsche Numis. Go ahead, please.
Damian McNeela
analystHello there. Good morning, everyone, and I appreciate you taking the questions. My first one concerns US combustible, specifically pricing. I was hoping you might give us a bit more detail on pricing across the subsegments where you operate, and on what the outlook for pricing in 2026 could look like, given how strong last year was. My second question relates to capex. You've signaled an increase this year. I was just wondering if that capex level is what we ought to expect in the years beyond 2026.
Tadeu Marroco
executiveThank you, Daniel. Now, regarding capex, we're stepping things up as a result of investments primarily in the modern oral segment. The bulk of capex at present is being redirected toward the new categories, and it's giving us room to keep expanding. Our expectations aren't for anything dramatically above where we sit right now, and that's working well for us, since at such a level we can still stay very near 100% of operating conversion. This isn't a constraint; it's simply the reality that capex at this level meets the needs of the business while, at the same time, positioning us well to keep delivering high levels of operating cash conversion, which really helps with the financial flexibility and capital allocation that Javed mentioned. Turning to US combustibles, I'm not in a position to discuss pricing, and what I can tell you is that price elasticity remains quite benign in the US when you look at the price of a cigarette relative to average household income. Naturally, there's a dynamic at play owing to the specific tax — when the price of a pack of cigarettes goes up, the manufacturer gains more than what the consumer perceives as a price increase, and that's helpful too.
Tadeu Marroco
executiveReynolds has been laddering a number of our brands. We did that with Newport and it worked very well. We've also launched Pall Mall Select, which is another laddering effort, and now Doral, as I mentioned, is in the pilot phase, which we expect to expand into more states. I'm not able to speculate with you about pricing in the future.
Damian McNeela
analystAppreciate it.
Operator
operatorThanks, everybody. Thanks. Looks like that was the final question we had on the phone today. So with that, I'd like to turn the call back to Victoria. Victoria, over to you.
Victoria Buxton
executiveApologies, and many thanks to all of you for those questions. Unfortunately, that's all the time we can spare today. Should you have submitted a question through the web, the IR team will be glad to respond to it as soon as possible. At this point, I'd like to pass things back to Tadeu for his closing remarks.
Tadeu Marroco
executiveAlright. Thanks to everyone for tuning in today and for the questions you sent our way. In closing, I feel confident that the right building blocks are in place for us to deliver our mid-term algorithm, and that's backed by delivering 2025 results at the top end of guidance. We'll keep rewarding shareholders through strong cash returns — our progressive dividend, a sustainable share buyback — and that enables us to deliver long-term growth and value creation. Thanks once more for joining us. I look forward to seeing many of you at the CAGNY conference next week, where we present on the 18th of February.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete British American Tobacco p.l.c. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to British American Tobacco p.l.c. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in British American Tobacco p.l.c. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.